AzTrials
AzTrials

Maxillary SinusNCT06846632

Graftless Technique in Open Maxillary Sinus Lifting Using PEEK Versus Ti -Meshwork

A study testing PEEK and titanium meshwork in people with Maxillary Sinus, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to assess the amount of bone formation with PEEK (intervention group) in comparison with Titanium Meshwork (control group) in maxillary sinus lifting using CBCT and assessment of the biocompatibility of the Meshwork and PEEK with the schniederian membrane integrity. Read more about this study

Who is it for?
Ages 25 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Maxillary Sinus
What is being tested?
PEEK and titanium meshwork
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteEgypt
Study dates
3 May 2024to 3 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • • Posterior edentulous ridges with pneumatized maxillary sinus and remaining bone height of 3 to 6 mm.
  • Patient age ranges from 25 to 50 years.
  • ASA physical status I and II.
  • Patients willing to be a part of the study and ready to give their consent in writing for the same.
  • Patient not complains from maxillary sinusitis
  • Patients are free from T.M.J disorders, abnormal oral habits such as bruxism.
  • Patient with good oral hygiene.

Who cannot join

  • • Untreated gingivitis, periodontitis.
  • Subjected to irradiation in the head and neck area less than 1 year before implantation.
  • Untreated periodontitis.
  • Insufficient oral hygiene and motivation.
  • Pregnant or nursing.
  • Bone pathology.
Show all 10Show fewer
  • Patient with blood disease.
  • Patient with any systematic disease that may affect normal healing.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Treated or under treatment with intravenous amino-bisphosphonates.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry Cairo University

    Cairo, 14444

Other trials in Egypt

About this study

Official title: Graftless Technique in Open Maxillary Sinus Lifting Using Poly-Ether-Ether-Ketone Versus Titanium Meshwork for Evaluation of Bone Quantity: Randomized Clinical Trials

The aim of the study is to assess the amount of bone formation with PEEK (intervention group) in comparison with Titanium Meshwork (control group) in maxillary sinus lifting using CBCT and assessment of the biocompatibility of the Meshwork and PEEK with the schniederian membrane integrity.

Read the detailed description

All patients involved in this study will be divided into two equal groups, each group will be; (Tested group): PEEK after maxillary sinus lifts (Caldwell luc approach). (Control group): Titanium meshwork after maxillary sinus lifts (Caldwell luc approach).

Clinical evaluation:

A through medical and dental history followed by clinical examination was carried out for all patients. Clinical measurements were taken to ensure patient adherence to our initial inclusion criteria prior to further investigations.

A preoperative digital panoramic radiograph with 1:1 magnification was taken for each patient as a primary survey in order to exclude the presence of any lesion at the area of interest and take a primary measurement for the residual bone height of maxillary sinus.

CBCT will be taken in order to design the custom-made PEEK model and its guide of external window before the milling.

Intra operative procedures for two groups:

The operation was carried out with the patient under local anesthesia (2% Lido HCl with 1:100,000 epinephrine). The perioral areas were aseptically prepared. A crestal incision was made on the midline of the gingiva attached to the edentulous ridge. The flap was elevated carefully and extended labially to expose the bone. A mesial and distal vertical releasing incision will be made as needed. The mucosal flap was denuded subperiosteally to fully expose the sharp and thin alveolar ridge and the lateral wall of the maxillary sinus. Extreme care was taken to radically elevate the sinus membrane from the lateral access window opened by using an electric-motor drill with appropriate water cooling. The floor, lateral wall, medial and posterior wall of the sinus membrane were meticulously detached and pushed upward for the placement of PEEK in intervention group and titanium meshwork in control group.

  • Follow up: Patients will be evaluated after 3 days and weekly for the first month and then after 6 months Radiographic assessment will be achieved by CBCT scan 6 months postoperatively to calculate the amount of vertical bone gain.
Conditions
Maxillary Sinus
Being tested
PEEK, titanium meshwork
Keywords
maxillary sinus lifting , PEEK , titanium meshwork

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PEEKDevice

    Also called poly ether ether ketone

    placement of PEEK after maxillary sinus lifting

  • titanium meshworkDevice

    placement of titanium meshwork after maxillary sinus lifting

Study groups in NCT06846632
Study groupRoleWhat they receive
placement of titanium meshwork after maxillary sinus liftingExperimentalplacement of titanium meshwork after maxillary sinus lifting
Receives: Device: titanium meshwork
placement of PEEK after maxillary sinus liftingExperimentalplacement of PEEK after maxillary sinus lifting
Receives: Device: PEEK

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone quantity

    assessment of bone quantity using CBCT

    Measured: at 6 months of maxillary sinus lifting

Secondary outcomes (1)
  1. Compatibility with Schneiderian membrane

    assessment of the biocompatibility with Schneiderian membrane

    Measured: at 6 months of maxillary sinus lifting

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Feb 2025
  2. Study start3 May 2024
  3. Primary completion3 Oct 2024
  4. Study completion3 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06846632
Sponsor's protocol ID
33-6-24
Status last verified
Feb 2025
First submitted
16 Feb 2025
Last updated
26 Feb 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing PEEK and titanium meshwork in people with Maxillary Sinus, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone quantity (time frame: at 6 months of maxillary sinus lifting). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in